The European landscape is witnessing a unique evolution in the perception of psychedelics. Long stigmatized, these substances are now receive attention for their medical applications. From the Netherlands, where clinical trials are underway, to the UK, where public discourse is expanding, Europe plays a leading role in this transformation of copyri